Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
pandemic
Pharma
SK Bioscience acquires 7% stake in struggling Novavax for $85M
Novavax has enhanced its partnership with SK Bioscience, which has acquired a 7% stake in Novavax, paying $85 million for 6.5 million shares.
Kevin Dunleavy
Aug 9, 2023 10:41am
SK plots next growth phase with plans for $261M campus in Korea
Feb 9, 2023 8:37am
The top 10 generic drug makers by 2021 revenue
Jul 18, 2022 3:00am
Moderna's head of marketing ops on COVID marketing
Jul 7, 2022 8:05am
Takeda CEO Weber says pandemic, war could lower drug prices
Jun 2, 2022 7:42am
Call for nominations: The Most Influential People in Biopharma
Jan 25, 2022 12:00pm